FDA Approved: DANTROLENE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for dantrolene sodium from Amneal Pharmaceuticals of New York LLC (ANDA076856), allowing continued marketing of the gene…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Hyperthermia
• Muscle Spasticity

Drugs mentioned

• Dantrolene Sodium (Dantrolene Sodium)

Snippet

SUPPL AP for DANTROLENE SODIUM (DANTROLENE SODIUM)